Contact Information
Company Information
Company
Cognito Therapeutics, Inc.
Total Funding
227015297.0
Technologies
Outlook
Amazon AWS
Greenhouse.io
Mobile Friendly
Vimeo
Google Tag Manager
Facebook Custom Audiences
Facebook Login (Connect)
Facebook Widget
Hubspot
Remote
Keywords
medical equipment manufacturing
neuromodulation
alzheimer's treatment
gamma waves
non-invasive therapy
brain function preservation
cognitive decline
brain volume loss
daily function
clinical studies
fda breakthrough device designation
sensor stimulation
neurodegenerative disease
synaptic plasticity
scientific research
wearable device
brain health improvement
neural activity
clinical trial results
eeg target engagement
treatment adherence
safety profile
patient convenience
home treatment
cognitive function
functional symptoms
neurotherapeutics
cost-effectiveness
neural stimulation
myelin gene expression
adverse events
neurobiology
phase 2 trial
brain structure
personalized treatment
medical device development
treatment options
patient recruitment
hospitals engagement
research collaboration
healthcare innovation
patient population
memory preservation
clinical trial phases
health outcomes
brain electroactivity
clinical efficacy
medical research
neurotechnology
disease-modifying treatments
alzheimer's disease
neurodegenerative diseases
sensory stimulation
gamma wave activity
clinical trials
digital therapeutics
patient-centric approach
home-based treatment
auditory stimulation
visual stimulation
brain health
innovative healthcare solutions
central nervous system disorders
healthcare collaboration
early adopters
clinical development
patient quality of life
biotechnology
optogenetics
therapeutic devices
healthcare technology
neurological therapeutics
cognitive disorders
patient engagement
healthcare providers
educational outreach
medical devices
hospital & health care
health care
health
wellness & fitness
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans